<DOC>
	<DOCNO>NCT02525887</DOCNO>
	<brief_summary>This observation look patient care decision primary healthcare provider utilize result DNA test patient ' metabolic pathway use 2C19 , 2C9 , 2D6 , 3A4 , Factor II , Factor V MTHFR VKORC1 . Findings data collection publish optimize benefit pharmacogenomics test publish health outcome .</brief_summary>
	<brief_title>Identify Genetic Variations That Affect The Ability Patients To Metabolize Drugs Through Metabolic Pathways</brief_title>
	<detailed_description>This study analyze de-identified data patient identify primary healthcare provider DNA sample collect ; medical history medication time DNA sample collect ; date DNA pathway test result . The study collect assess patient data healthcare provider explain result DNA test patient make applicable change healthcare plan base DNA pathway result . Patients return healthcare provider minimum ninety ( 90 ) day follow-up assess outcome care plan change start DNA result provide . This study collect healthcare provider provide outcome healthcare plan change .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Brain Diseases , Metabolic</mesh_term>
	<criteria>1 . Adult male female patient age 18 old 2 . Prescribed least one medication metabolic pathway assess enrol study . 3 . Completed DNA test pathway review observation . 1 . Anticipated life expectancy le 1 month . 2 . Employee investigator , direct involvement propose study study direction investigator , well immediate family member employee primary care provider .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>